ISU Abxis Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.33%

ISU Abxis Co. Ltd (086890) has an Asset Resilience Ratio of 0.33% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 086890 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩538.59 Million

≈ $365.00K USD Cash + Short-term Investments

Total Assets

₩165.68 Billion

≈ $112.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how ISU Abxis Co. Ltd's Asset Resilience Ratio has changed over time. See ISU Abxis Co. Ltd (086890) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down ISU Abxis Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 086890 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩538.59 Million	0.33%
Total Liquid Assets	₩538.59 Million	0.33%

Asset Resilience Insights

Limited Liquidity: ISU Abxis Co. Ltd maintains only 0.33% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ISU Abxis Co. Ltd Industry Peers by Asset Resilience Ratio

Compare ISU Abxis Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	2.23%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%

Annual Asset Resilience Ratio for ISU Abxis Co. Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for ISU Abxis Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.90%	₩28.68 Billion ≈ $19.44 Million	₩160.23 Billion ≈ $108.59 Million	-39.82pp
2023-12-31	57.72%	₩119.34 Billion ≈ $80.87 Million	₩206.74 Billion ≈ $140.10 Million	+16.96pp
2022-12-31	40.76%	₩55.96 Billion ≈ $37.92 Million	₩137.27 Billion ≈ $93.03 Million	+14.53pp
2021-12-31	26.23%	₩39.63 Billion ≈ $26.86 Million	₩151.09 Billion ≈ $102.39 Million	+5.12pp
2020-12-31	21.11%	₩17.47 Billion ≈ $11.84 Million	₩82.75 Billion ≈ $56.08 Million	-12.82pp
2019-12-31	33.92%	₩31.47 Billion ≈ $21.33 Million	₩92.76 Billion ≈ $62.86 Million	+15.14pp
2018-12-31	18.79%	₩13.12 Billion ≈ $8.89 Million	₩69.84 Billion ≈ $47.33 Million	-19.51pp
2017-12-31	38.30%	₩29.78 Billion ≈ $20.18 Million	₩77.77 Billion ≈ $52.70 Million	+13.45pp
2016-12-31	24.85%	₩14.87 Billion ≈ $10.08 Million	₩59.84 Billion ≈ $40.55 Million	-8.49pp
2015-12-31	33.34%	₩23.34 Billion ≈ $15.82 Million	₩70.00 Billion ≈ $47.44 Million	+32.72pp
2014-12-31	0.62%	₩304.76 Million ≈ $206.53K	₩48.99 Billion ≈ $33.20 Million	--

pp = percentage points

About ISU Abxis Co. Ltd

KQ:086890 Korea Pharmaceuticals

Market Cap

$85.89 Million

₩126.74 Billion KRW

Market Cap Rank

#19763 Global

#1119 in Korea

Share Price

₩4760.00

Change (1 day)

-1.86%

52-Week Range

₩4410.00 - ₩6240.00

All Time High

₩22450.00